Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - 15 Oct 2024 Form 4 Insider Report for NATURES SUNSHINE PRODUCTS INC (NATR)

Role: 10%+ Owner
Signature: Shanghai Fosun Pharmaceutical (Group) Co., Ltd., By: /s/ WU Yifang/Chairman
Issuer symbol: NATR
Transactions as of: 15 Oct 2024
Net transactions value: -$29,946
Form type: 4
Filing time: 17 Oct 2024, 06:00:14 UTC
Previous filing: 15 Oct 2024
Next filing: 27 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NATR	Common Stock	Sale	$29,946	-2,300	-3.5%	$13.02	64,167	15 Oct 2024	by Fosun Industrial Co., Limited	F1
holding	NATR	Common Stock						2,854,607	15 Oct 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fosun Industrial Co., Limited is a wholly-owned subsidiary of the Reporting Person.